Madrigal Pharmaceuticals, Inc. MDGL Investment Purchases
Investment Purchases at other companies
Other financials
Where this comes from
Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt.
The official record: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Madrigal Pharmaceuticals, Inc.'s investment purchases.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Madrigal Pharmaceuticals, Inc.'s investment purchases?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported investment purchases of $157.83M in Q1 2026.
- How has Madrigal Pharmaceuticals, Inc.'s investment purchases changed year-over-year?
- Madrigal Pharmaceuticals, Inc.'s investment purchases increased by 20.7% year-over-year, from $130.81M to $157.83M.
- What is the long-term trend for Madrigal Pharmaceuticals, Inc.'s investment purchases?
- Over 4 years (2021 to 2025), Madrigal Pharmaceuticals, Inc.'s investment purchases has grown at a 27.7% compound annual growth rate (CAGR), from $394.12M to $1.05B.
- What does investment purchases mean?
- Cash spent to buy financial investments or marketable securities.
- How do you interpret investment purchases?
- High outflows indicate significant cash reserves being deployed into short-term investments rather than immediate operational spending.
- How does investment purchases compare across companies?
- Standard for companies managing treasury assets to preserve capital.